NASDAQ · Financial Statements
Solid Biosciences Inc. (SLDB) Financial Statements
$6.87
NASDAQ: SLDB
Market Cap $676.35M
Overview Financials Dividend Solid Biosciences Inc. most recently reported annual revenue of $0, net profit of $-174.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $14.0M $8.0M $0 $0 $0 Operating Profit $-72.0M $-106.0M $-104.0M $-130.0M $-179.0M Net Profit $-72.0M $-86.0M $-96.0M $-125.0M $-174.0M EPS $-10.14 $-10.10 $-4.83 $-3.06 $-1.99 Op Margin -530.5% -1315.2% — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $232.0M $260.0M $165.0M $189.0M $233.0M Total Liabilities $24.0M $49.0M $38.0M $51.0M $53.0M Cash $119.0M $155.0M $74.0M $80.0M $60.0M Borrowings $2.0M $29.0M $26.0M $24.0M $21.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-78.0M $-98.0M $-94.0M $-100.0M $-156.0M Investing Cash Flow $-92.0M $56.0M $8.0M $-17.0M $-60.0M Financing Cash Flow $0 $0 $0 $-4.0M $0 Net Cash Flow $-34.0M $36.0M $-81.0M $6.0M $-20.0M Free Cash Flow $-79.0M $-101.0M $-96.0M $-101.0M $-157.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.12 EV / EBITDA -2.71 FCF Yield -27.02% Quick Ratio 13.82 Interest Coverage 0.00 Return 1Y 18.05% Return 3Y 76.55% Return 5Y -78.74%
Screens featuring this stock